We speculate that ZIP14 could prove to be not only a new biomarker of metabolic stress but possibly a future medical target in the treatment of obesity, affecting intracellular zinc regulation and adipogenesis and thereby supporting a healthy adipose tissue expansion. Here, SLC39A14 is linked to obesity due to melanocortin 4 receptor deficiency.